Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing.
Prophecy.io, a Palo Alto, Calif.-based provider of a SaaS based low code data engineering platform, raised $6m in funding.
OpsCruise, a Sunnyvale, CA-based cloud application observability company, emerged from stealth with $5m in seed funding.
GiveSignup, a Moorestown, N.J.-based Supporter Engagement Platform for nonprofit revenue generation, closed a $3.2m Series A funding round.
Gettacar, a Philadelphia, PA-based online car buying startup, raised $25m in funding, bringing the total raised to $48m.
Orna Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series A financing.
Saltmine, a San Francisco, CA-based end-to-end digital workplace platform enabling corporations to optimize their office space, raised $20m in Series A funding.
Petal, a New York, NY, and Richmond, VA-based credit card company, closed a more than $125m committed debt facility.
Blueshift, a San Francisco, CA-based AI-Powered Customer Data Platform, raised $30m in Series C financing.
Workiz, a San Diego, CA-based field service management and communication startup, closed a $13m Series B funding round.
BrandMaker, an Atlanta, Georgia-based provider of Marketing Operations and Marketing Resource Management solutions, secured a strategic majority investment from Rubicon Technology Partners.
BeSmartee, a Huntington Beach, Calif.-based software provider and founder of modern digital mortgage platforms for financial institutions, secured a strategic growth investment from M33 Growth, a Boston-based venture and growth stage investment firm.
GoStork, a NYC-based fertility marketplace, raised $760,000 in seed funding.
VidMob, a NYC-based Intelligent Creative platform provider, closed its Series C financing, raising $50m in expansion capital.
AbSci, a Vancouver, Wash.-based synthetic biology company that unifies biologic drug discovery and development processes, received a strategic equity investment from Merck Global Health Innovation Fund (Merck GHI).